171 related articles for article (PubMed ID: 23826136)
1. Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central China.
Ma Y; Zheng S; Wang N; Duan Y; Sun X; Jin J; Zang W; Li M; Wang Y; Zhao G
PLoS One; 2013; 8(6):e66795. PubMed ID: 23826136
[TBL] [Abstract][Full Text] [Related]
2. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
[TBL] [Abstract][Full Text] [Related]
4. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L
BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656
[TBL] [Abstract][Full Text] [Related]
5. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases.
Giuliani M; Rezza G; Lepri AC; Di Carlo A; Maini A; Crescimbeni E; Palamara G; Prignano G; Caprilli F
Sex Transm Dis; 2000 Feb; 27(2):87-92. PubMed ID: 10676975
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1 cosmopolitan and HTLV-2 subtype b among pregnant women of non-endemic areas of Argentina.
Berini CA; Delfino C; Torres O; García G; Espejo R; Pianciola L; Juarez M; Arribere G; Nadal M; Eirin ME; Biglione MM
Sex Transm Infect; 2013 Jun; 89(4):333-5. PubMed ID: 23220782
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile.
Barrientos A; Lopez M; Sotomayor C; Pilleux L; Calderón S; Navarrete M; Otth C
J Med Virol; 2011 Apr; 83(4):745-8. PubMed ID: 21328393
[TBL] [Abstract][Full Text] [Related]
10. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
Kleine Neto W; Sanabani SS; Jamal LF; Sabino EC
Rev Soc Bras Med Trop; 2009; 42(3):264-70. PubMed ID: 19684973
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of human retroviruses in blood samples from patients with hepatitis B and C in São Paulo, Brazil.
Caterino-de-Araujo A; Campos KR; Petrucci TVB; Silva RXD; Lemos MF; Moreira RC
Rev Soc Bras Med Trop; 2020; 53():e20190378. PubMed ID: 32049201
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994.
Broutet N; de Queiroz Sousa A; Basilio FP; Sá HL; Simon F; Dabis F
Int J STD AIDS; 1996; 7(5):365-9. PubMed ID: 8894828
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of human T-cell leukemia virus in blood donors in China.
Li L; Ou S; Huang C; Zhou X; Ge H; Li J; Zeng J; Zhou A; He L; Xu Q; Wu J; Li L; Wang C; Zang L; Huang L; Niu L; Han H; Zhang G; Wan J; Wang F; Xu T; Zhao B; Qian L; Wu Y; Liu Z
Transfusion; 2019 Jul; 59(7):2361-2367. PubMed ID: 30985961
[TBL] [Abstract][Full Text] [Related]
15. HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections.
Berini CA; Pando MA; Bautista CT; Eirin ME; Martinez-Peralta L; Weissenbacher M; Avila MM; Biglione MM
J Med Virol; 2007 Dec; 79(12):1914-20. PubMed ID: 17935172
[TBL] [Abstract][Full Text] [Related]
16. Human T-lymphotropic Virus Co-infections in Adults Infected With Human Immunodeficiency Virus.
Rossheim AE; Cunningham TD; Troy SB
Am J Med Sci; 2016 Sep; 352(3):258-60. PubMed ID: 27650229
[TBL] [Abstract][Full Text] [Related]
17. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human T-cell lymphotropic virus (HTLV-1/2) in individuals from public health centers in Mozambique.
Caterino-de-Araujo A; Magri MC; Costa EA; Manuel RC
AIDS Res Hum Retroviruses; 2010 May; 26(5):559-61. PubMed ID: 20438381
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 and -2 in a first-time blood donor population in Northeastern Brazil: Prevalence, molecular characterization, and evidence of intrafamilial transmission.
Ribeiro IP; Kozlowski AG; Dias de Matos MA; da Costa E Silva ÁM; Dos Santos Carneiro MA; Vicente ACP; Martins RMB
J Med Virol; 2018 Oct; 90(10):1651-1657. PubMed ID: 29797609
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of HTLV-I/II in Argentina: an overview.
Gastaldello R; Hall WW; Gallego S
J Acquir Immune Defic Syndr; 2004 Mar; 35(3):301-8. PubMed ID: 15076246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
